US Stock MarketDetailed Quotes

SYRE Spyre Therapeutics

Watchlist
  • 27.785
  • +0.785+2.91%
Trading Nov 22 14:14 ET
1.63BMarket Cap-18523P/E (TTM)

Spyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
-61.96%886K
0
0
10.08%688K
-85.46%198K
-87.57%2.33M
-95.39%168K
Operating revenue
--0
--0
--0
-61.96%886K
--0
--0
10.08%688K
-85.46%198K
-87.57%2.33M
-95.39%168K
Cost of revenue
Gross profit
Operating expense
66.62%55.39M
49.92%44.15M
151.39%47.77M
48.61%129.45M
147.05%47.75M
75.62%33.24M
27.77%29.45M
-26.35%19M
3.23%87.11M
-19.75%19.33M
Selling and administrative expenses
24.04%10.65M
-4.57%11.51M
145.72%12.85M
40.01%39.95M
177.06%14.07M
23.48%8.58M
57.16%12.06M
-40.76%5.23M
4.44%28.53M
-30.46%5.08M
-General and administrative expense
24.04%10.65M
-4.57%11.51M
145.72%12.85M
40.01%39.95M
177.06%14.07M
23.48%8.58M
57.16%12.06M
-40.76%5.23M
4.44%28.53M
-30.46%5.08M
Research and development costs
81.44%44.74M
87.71%32.64M
153.54%34.93M
52.79%89.5M
136.35%33.68M
105.89%24.66M
13.09%17.39M
-18.86%13.78M
2.65%58.58M
-15.08%14.25M
Operating profit
-66.62%-55.39M
-53.50%-44.15M
-154.04%-47.77M
-51.64%-128.56M
-149.21%-47.75M
-77.25%-33.24M
-28.26%-28.76M
23.06%-18.81M
-29.14%-84.78M
6.26%-19.16M
Net non-operating interest income expense
314.39%5.18M
1,591.43%5.92M
955.24%4.43M
634.41%6.15M
906.34%4.13M
334.38%1.25M
236.54%350K
1,100.00%420K
654.05%837K
1,105.88%410K
Non-operating interest income
314.39%5.18M
1,591.43%5.92M
955.24%4.43M
634.41%6.15M
906.34%4.13M
334.38%1.25M
236.54%350K
1,100.00%420K
654.05%837K
1,105.88%410K
Other net income (expense)
-131.81%-18.8M
99.68%-610K
-570.83%-483K
-3,091,314.29%-216.4M
-61,000.00%-19.55M
-33,895.83%-8.11M
-3,773,380.00%-188.66M
-140.00%-72K
94.26%-7K
-113.33%-32K
Gain on sale of security
----
----
----
---83.53M
--0
---25.36M
---58.17M
----
----
----
Special income (charges)
--0
--0
----
---113.74M
--1.84M
--14.91M
---130.49M
----
--0
--0
-Less:Other special charges
----
----
----
--130.19M
--0
---298K
--130.49M
----
----
----
-Gain on sale of property,plant,equipment
--0
----
----
--16.45M
--1.84M
--14.61M
----
----
--0
--0
Other non- operating income (expenses)
-902.82%-18.8M
-7,525.00%-610K
-570.83%-483K
-273,185.71%-19.13M
-66,750.00%-21.39M
9,658.33%2.34M
-260.00%-8K
-140.00%-72K
94.26%-7K
-113.33%-32K
Income before tax
-72.08%-69.01M
82.11%-38.84M
-137.43%-43.83M
-303.59%-338.82M
-236.35%-63.18M
-117.45%-40.1M
-872.82%-217.07M
24.46%-18.46M
-27.86%-83.95M
8.03%-18.78M
Income tax
500.00%18K
0
188.89%32K
80.88%-26K
0
101.44%3K
-22.22%7K
-36K
-196.45%-136K
65.22%38K
Net income
-72.11%-69.03M
82.11%-38.84M
-138.07%-43.86M
-304.21%-338.79M
-235.67%-63.18M
-119.96%-40.11M
-872.45%-217.08M
24.61%-18.42M
-27.38%-83.82M
7.94%-18.82M
Net income continuous Operations
-72.11%-69.03M
82.11%-38.84M
-138.07%-43.86M
-304.21%-338.79M
-235.67%-63.18M
-119.96%-40.11M
-872.45%-217.08M
24.61%-18.42M
-27.38%-83.82M
7.94%-18.82M
Minority interest income
Net income attributable to the parent company
-72.11%-69.03M
82.11%-38.84M
-138.07%-43.86M
-304.21%-338.79M
-235.67%-63.18M
-119.96%-40.11M
-872.45%-217.08M
24.61%-18.42M
-27.38%-83.82M
7.94%-18.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-72.11%-69.03M
82.11%-38.84M
-138.07%-43.86M
-304.21%-338.79M
-235.67%-63.18M
-119.96%-40.11M
-872.45%-217.08M
24.61%-18.42M
-27.38%-83.82M
7.94%-18.82M
Basic earnings per share
-23.26%-1.06
98.53%-0.59
85.28%-0.72
44.65%-13.76
62.64%-1.7522
82.23%-0.86
-494.67%-40.14
47.14%-4.89
0.64%-24.86
39.64%-4.69
Diluted earnings per share
-23.26%-1.06
98.53%-0.59
85.28%-0.72
44.65%-13.76
62.64%-1.7522
82.23%-0.86
-494.67%-40.14
47.14%-4.89
0.64%-24.86
39.64%-4.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 000-61.96%886K0010.08%688K-85.46%198K-87.57%2.33M-95.39%168K
Operating revenue --0--0--0-61.96%886K--0--010.08%688K-85.46%198K-87.57%2.33M-95.39%168K
Cost of revenue
Gross profit
Operating expense 66.62%55.39M49.92%44.15M151.39%47.77M48.61%129.45M147.05%47.75M75.62%33.24M27.77%29.45M-26.35%19M3.23%87.11M-19.75%19.33M
Selling and administrative expenses 24.04%10.65M-4.57%11.51M145.72%12.85M40.01%39.95M177.06%14.07M23.48%8.58M57.16%12.06M-40.76%5.23M4.44%28.53M-30.46%5.08M
-General and administrative expense 24.04%10.65M-4.57%11.51M145.72%12.85M40.01%39.95M177.06%14.07M23.48%8.58M57.16%12.06M-40.76%5.23M4.44%28.53M-30.46%5.08M
Research and development costs 81.44%44.74M87.71%32.64M153.54%34.93M52.79%89.5M136.35%33.68M105.89%24.66M13.09%17.39M-18.86%13.78M2.65%58.58M-15.08%14.25M
Operating profit -66.62%-55.39M-53.50%-44.15M-154.04%-47.77M-51.64%-128.56M-149.21%-47.75M-77.25%-33.24M-28.26%-28.76M23.06%-18.81M-29.14%-84.78M6.26%-19.16M
Net non-operating interest income expense 314.39%5.18M1,591.43%5.92M955.24%4.43M634.41%6.15M906.34%4.13M334.38%1.25M236.54%350K1,100.00%420K654.05%837K1,105.88%410K
Non-operating interest income 314.39%5.18M1,591.43%5.92M955.24%4.43M634.41%6.15M906.34%4.13M334.38%1.25M236.54%350K1,100.00%420K654.05%837K1,105.88%410K
Other net income (expense) -131.81%-18.8M99.68%-610K-570.83%-483K-3,091,314.29%-216.4M-61,000.00%-19.55M-33,895.83%-8.11M-3,773,380.00%-188.66M-140.00%-72K94.26%-7K-113.33%-32K
Gain on sale of security ---------------83.53M--0---25.36M---58.17M------------
Special income (charges) --0--0-------113.74M--1.84M--14.91M---130.49M------0--0
-Less:Other special charges --------------130.19M--0---298K--130.49M------------
-Gain on sale of property,plant,equipment --0----------16.45M--1.84M--14.61M----------0--0
Other non- operating income (expenses) -902.82%-18.8M-7,525.00%-610K-570.83%-483K-273,185.71%-19.13M-66,750.00%-21.39M9,658.33%2.34M-260.00%-8K-140.00%-72K94.26%-7K-113.33%-32K
Income before tax -72.08%-69.01M82.11%-38.84M-137.43%-43.83M-303.59%-338.82M-236.35%-63.18M-117.45%-40.1M-872.82%-217.07M24.46%-18.46M-27.86%-83.95M8.03%-18.78M
Income tax 500.00%18K0188.89%32K80.88%-26K0101.44%3K-22.22%7K-36K-196.45%-136K65.22%38K
Net income -72.11%-69.03M82.11%-38.84M-138.07%-43.86M-304.21%-338.79M-235.67%-63.18M-119.96%-40.11M-872.45%-217.08M24.61%-18.42M-27.38%-83.82M7.94%-18.82M
Net income continuous Operations -72.11%-69.03M82.11%-38.84M-138.07%-43.86M-304.21%-338.79M-235.67%-63.18M-119.96%-40.11M-872.45%-217.08M24.61%-18.42M-27.38%-83.82M7.94%-18.82M
Minority interest income
Net income attributable to the parent company -72.11%-69.03M82.11%-38.84M-138.07%-43.86M-304.21%-338.79M-235.67%-63.18M-119.96%-40.11M-872.45%-217.08M24.61%-18.42M-27.38%-83.82M7.94%-18.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -72.11%-69.03M82.11%-38.84M-138.07%-43.86M-304.21%-338.79M-235.67%-63.18M-119.96%-40.11M-872.45%-217.08M24.61%-18.42M-27.38%-83.82M7.94%-18.82M
Basic earnings per share -23.26%-1.0698.53%-0.5985.28%-0.7244.65%-13.7662.64%-1.752282.23%-0.86-494.67%-40.1447.14%-4.890.64%-24.8639.64%-4.69
Diluted earnings per share -23.26%-1.0698.53%-0.5985.28%-0.7244.65%-13.7662.64%-1.752282.23%-0.86-494.67%-40.1447.14%-4.890.64%-24.8639.64%-4.69
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data